Peripheral Intravenous (IV) Catheters

Peripheral Intravenous (IV) Catheters

Global Peripheral Intravenous (IV) Catheters Market to Reach US$7.7 Billion by 2030

The global market for Peripheral Intravenous (IV) Catheters estimated at US$5.2 Billion in the year 2023, is expected to reach US$7.7 Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2023-2030. Short Catheters, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$4.6 Billion by the end of the analysis period. Growth in the Integrated / Closed Catheters segment is estimated at 6.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.4 Billion While China is Forecast to Grow at 9.0% CAGR

The Peripheral Intravenous (IV) Catheters market in the U.S. is estimated at US$1.4 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2030 trailing a CAGR of 9.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.3% and 5.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Global Peripheral Intravenous (IV) Catheters Market - Key Trends and Drivers Summarized

Peripheral Intravenous (IV) Catheters are essential medical devices used extensively in healthcare settings for the administration of medications, fluids, electrolytes, and nutritional compounds directly into a patient`s venous system. Their primary function is to provide immediate access to the bloodstream, facilitating rapid absorption and effect of administered substances. These catheters are most commonly placed in peripheral veins such as those in the arms or hands, but alternative sites can include the scalp veins in infants or the feet in adults when other sites are not viable. The catheter itself consists of a flexible tube that is inserted into a vein using a needle, which is subsequently removed, leaving only the tube in place. This setup minimizes the patient`s discomfort and maintains an open channel to the bloodstream for the required duration of treatment, which can range from a few hours to several weeks, depending on the clinical situation.

The design and material composition of peripheral IV catheters have evolved to enhance patient safety and comfort. Traditionally made from polyurethane or silicone, these catheters are designed to be biocompatible to reduce the risk of venous irritation and minimize the likelihood of allergic reactions. Recent innovations include the development of catheters with antimicrobial and antithrombotic coatings to reduce the incidence of catheter-related bloodstream infections and thrombosis, respectively. Furthermore, the use of safety-engineered devices with retractable needles has become more widespread, significantly reducing the incidence of needlestick injuries among healthcare providers. These catheters come in various gauges and lengths, allowing for customization based on patient needs and the viscosity of the infused substance, thus optimizing the flow rates and reducing the risks of complications.

The growth in the peripheral intravenous catheter market is driven by several factors, including advancements in catheter technology, an increase in the prevalence of chronic diseases, and a rising emphasis on healthcare quality and patient safety. The aging population globally has led to a higher incidence of chronic conditions such as diabetes, cancer, and cardiovascular diseases, all of which often require IV therapeutic treatment modalities. Additionally, the growing trend towards minimally invasive treatments has fueled the demand for devices that can be efficiently managed in outpatient settings, including home healthcare. The market is also benefiting from the increasing investment in healthcare infrastructure and services, particularly in emerging economies where access to basic medical care is expanding. Furthermore, ongoing research and development activities aimed at further minimizing infection rates and improving patient comfort are poised to propel the adoption of newer, more advanced peripheral IV catheter products. This market dynamic is supported by a competitive landscape where manufacturers are continually innovating to meet the stringent safety standards required by regulatory authorities worldwide, ensuring sustained growth in this sector.

Select Competitors (Total 45 Featured) -

• Argon Medical Devices, Inc.
• B. Braun Medical Inc.
• Becton, Dickinson and Company
• ICU Medical, Inc.
• MEDEREN Neotech Ltd
• Nipro Medical Corporation
• Delta Med S.p.A
• Vogt Medical GMBH
• Teleflex, Inc.
• Terumo Medical Corporation
• Vygon SAS;

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.